Disease relevance of Erigeron

• AIM: To investigate the neuroprotective effect and mechanisms of scutellarin, a flavonoid extracted from Erigeron breviscapus Hand Mazz, against neuronal damage following cerebral ischemia/reperfusion [1].

High impact information on Erigeron

• Changes in the xanthophyll cycle and fluorescence quenching indicate light-dependent early events in the action of paraquat and the mechanism of resistance to paraquat in Erigeron canadensis (L.) cronq [2].
• Scutellarin was purified from the plant Erigeron breviscapus (Vant.) Hand.-Mazz [3].
• Four new and five known eudesmane-type sesquiterpenes were isolated from the aerial parts of Erigeron annus [4].
• Breviscapine is a flavonoid extracted from Erigeron breviscapus [5].
• N-(phosphonomethyl)glycine (glyphosate) resistance was previously reported in a horseweed [Conyza (=Erigeron) canadensis (L.) Cronq.] population from Houston, DE (P (0) (R) ) [6].

Associations of Erigeron with chemical compounds

• The scutellarin was extracted from dry Erigeron breviscapus [7].
• Quercetin, rhamnetin, isohamnetin, apigenin and luteolin were isolated from medicinal herbs: Erigeron canadensis L., Anthyllis vulneraria L. and Pyrola chloranta L [8].
• Two new cyclopentenone derivatives, erigerenones A (1) and B (2), and a new cyclooctadienone derivative, erigerenone C (3), were isolated from the aerial parts of Erigeron philadelphicus L [9].
• (5-Butyl-3-oxo-2,3-dihydrofuran-2-yl)-acetic acid was isolated from the flowers of Erigeron annuus as one of four germination inhibitory constituents [10].
• Effects of Erigeron breviscapus ethanol extract on neuronal oxidative injury induced by superoxide radical [11].

References